Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025
On Thursday, April 10, 2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, Dr. Wolfgang Winkelmayer will present a poster titled “Vadadustat for Treatment of Anemia in Older vs ...
BioPharma Dive1d
Character Biosciences raises $93M with an eye on vision loss drugs
The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...
NKF's KidneyCARE™ Study Celebrates One-Year Milestone, Enrolling Over 1,000 Patients Nationwide
The National Kidney Foundation (NKF) is proud to announce that its KidneyCARE (Community Access to Research Equity)™ Study – ...
scPharmaceuticals price target lowered to $12 from $20 at Maxim
Maxim analyst Naz Rahman lowered the firm’s price target on scPharmaceuticals (SCPH) to $12 from $20 but keeps a Buy rating on the shares after ...